Kidney International

Article	Citations
Subscription Information	1035
Back off to better blow up: acute GFR decrease at SGLT-2 inhibitor initiation	552
The authors reply	499
The latest model has just arrived! A new experimental mouse model of PLA2R1-associated membranous nephropathy	456
Table of Contents	431
An unusual case of ascites after kidney transplantation	252
In this issue	232
The authors reply:	231
The Case | Euglycemic ketoacidosis in a patient on continuous renal replacement therapy	214
Enough is enough: targeted eculizumab withdrawal in atypical hemolytic uremic syndrome	187
Endothelial-specific loss of Krüppel-Like Factor 4 triggers complement-mediated endothelial injury	166
Tolerogenic dendritic cells: promising cell therapy for acute kidney injury	155
Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease	147
Journal Club	133
In This Issue	131
Sex differences in cardiovascular disease burden in children with chronic kidney disease	128
Resazurin dye is an in vivo sensor of kidney tubular function	124
Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes	122
Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients	120
TRAIL induces podocyte PANoptosis via death receptor 5 in diabetic kidney disease	113
Editorial Board	111
PI3Kα in the pathogenesis and treatment of lupus nephritis	109
Challenges in maturation and integration of kidney organoids for stem cell–based renal replacement therapy	108
The Role of Sex and Gender in Acute Kidney Injury - Consensus Statements from the 33rd Acute Disease Quality Initiative	107
Subscription Information	102

In this issue	101
Editorial Board	100
James P. Knochel, MD, 1930–2022	99
Acute heart failure in a kidney transplant patient	99
Journal Club	98
Kidney protective mechanisms of SGLT2 inhibitors: evidence for a hemodynamic effect	97
The impact of genetic background on mouse models of kidney disease	95
Novel mechanisms of salt-sensitive hypertension	92
Caloric restriction reduces the pro-inflammatory eicosanoid 20-hydroxyeicosatetraenoic acid to protect from acute kidney injury	91
Validation of the ANCA renal risk score in a London cohort: potential impact of treatment on prediction outcome	90
Vitamin K and cardiovascular complications in chronic kidney disease patients	88
Editorial Board	87
Subscription Information	84
The authors reply	83
Journal Club	76
Strawberry gingivitis	76
The authors reply	75
Acknowledgment of reviewers	74
The Case | Hematuria and hypercalcemia in a kidney transplant recipient	71
Implementation science: a tool to narrow know-do gap and widen equity in kidney diseases and transplantation	71
Barriers to accessing essential medicines for kidney disease in low- and lower middle–income countries|	69
Going rogue: how autoantibodies become pathogenic	68
In this issue	68
The authors reply	65
in this issue	64
Table of Contents	63
In this issue	62
A team-based approach for testing biomarkers of kidney disease progression	60
In memoriam: Donal O’Donoghue, 1956–2021	60
Editorial Board	60
Hydroxycobalamin-induced pigmented effluent during dialysis	59
The Case | A paraneoplastic kidney injury?	59
Journal Club	58
Dietary sodium restriction in heart failure and chronic kidney disease: more evidence emerges	58
Polyploid tubular cells and chronic kidney disease	58
The authors reply	58
A PHD inhibitor prevents changes in the phosphoproteome and capillary rarefaction by CsA: treatment option for CKD?	58
Table of Contents	57
Tubular albumin uptake: is there evidence for a quantitatively important, receptor-independent mechanism?	57
The authors reply	57
The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms	57
In This Issue	56
Subscription Information	56
Editorial Board	55
TAMEing ADPKD with metformin: safe and effective?	55
Table of Contents	54
Table of Contents	54
Table of Contents	54
Acute kidney injury and “clogged chimneys”	53
Proximal-tubule molecular relay from early Protein diaphanous homolog 1 to late Rho-associated protein kinase 1 regulates kidney function in obesity-induced kidney damage	51

The characteristics of seronegative and seropositive non-hepatitis-associated cryoglobulinemic glomerulonephritis	51
Current kidney function parameters overestimate kidney tissue repair in reversible experimental kidney disease	51
Maybe the various forms of kidney disease are not so mechanistically different?	50
Single-cell lineage tracing approaches to track kidney cell development and maintenance	50
IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine	50
The authors reply	49
Subscription Information	48
Table of Contents	48
Endogenous adenine as a key player in diabetic kidney disease progression: an integrated multiomics approach	48
Genetic insights into rapid kidney function decline	48
Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors	48
Idiopathic collapsing glomerulopathy is associated with APOL1 high-risk genotypes or Mendelian variants in most affected individuals in a highly admixed population	47
Editorial Board	46
Subscription Information	46
The Case | Hypereosinophilia in a hemodialysis patient	46
War in Ukraine	45
Do the benefits of subcutaneous immunoglobulin therapy for secondary hypogammaglobulinemia in ANCA vasculitis extend beyond infection prevention?	44
Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C	44
Looking back and moving forward	43
Tolvaptan to prevent calcium oxalate crystal deposition in the kidney allograft after kidney transplantation for primary hyperoxaluria	43
Looking into the cholesterol crystal ball: is complement the answer?	43
in this issue	43
Function follows form: the quest for the best prognostic imaging biomarker in ADPKD	43
In memoriam: Shaul G. Massry	43
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy	42
JournalClub	42
Granuloma formation after peritoneal dialysis catheter–related infection by Mycobacterium chelonae	42
Editorial Board	41
PRECEDE/PROCEED framework for public health program planning in preparation for current and future unprecedented events for patients with kidney failure and living with a kidney transplant	40
Calculated versus measured albumin-creatinine ratio to predict kidney failure and death in people with chronic kidney disease	40
Challenges in the development of novel methodologies for measuring glomerular filtration rate	40
in this issue	40
Myeloid bodies in acute tubular injury	39
Endovascular treatment of nutcracker syndrome	39
Blood pressure adaptation in vertebrates: comparative biology	39
Trans-ethnic genome-wide association study of blood metabolites in the Chronic Renal Insufficiency Cohort (CRIC) study	39
Anti-aging mechanism of calorie restriction in humans	38
Could Plasmodium falciparum–related kidney disease stand as another example of interferonopathy?	38
Targeting WIP1 phosphatase promotes partial remission in experimental collapsing glomerulopathy	37
Tubular handling of filtered albumin	37
Significance of HLA-DQ in kidney transplantation: time to reevaluate human leukocyte antigen–matching priorities to improve transplant outcomes? An expert review and recommendations	37
A machine learning–based radiomic model for predicting urinary infection stone	36
Plasma cadmium is associated with increased risk of long-term kidney graft failure	36
Subscription Information	36
Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition	36
Both hyperglycemia and hyperuricemia aggravate acute kidney injury during cholesterol embolism syndrome despite opposite effects on kidney infarct size	36
In remembrance of Eberhard Ritz, MD (1938–2023)	35
Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report	35
Cardiac tamponade diagnosed on nephrologist-performed point-of-care ultrasonography	35
Table of Contents	35
Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality	35
Prioritizing water stewardship in kidney replacement therapies	35
Deletion of the proton receptor OGR1 in mouse osteoclasts impairs metabolic acidosis-induced bone resorption	34
The authors reply	34
Gene editing: a near future for the treatment of genetic kidney diseases	34
Murine models of uremic cardiomyopathy as a necessary tool to unravel mechanisms involved in cardiorenal syndrome	34
Should we consider calcimimetics as a therapeutic option for nephrotic syndrome?	34
Shifting the focus from managing the failing kidney allograft to supporting the patient with a failing kidney allograft	34
APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (contra)	34
Renovascular hypertension secondary to massive iliopsoas hematoma	33
Age-related changes in nephrosclerosis in a multiethnic living kidney donor cohort	33
A key gene in Drosophila eye development provides protection for tubules and glomeruli upon injury	33
The authors reply	33
Oncogenic osteomalacia related to an intramuscular mesenchymal tumor of the scalene muscles	33
Machine learning: it takes more than select models to draw general conclusions	33
When the pooled CRISPR screen meets kidney organoids: toward the identification of new genes and pathways	33
journal club	32
Parathyroid hormone oxidation in chronic kidney disease: clinical relevance?	32
Table of Contents	32
All the might of the osteocyte: emerging roles in chronic kidney disease	32
Long-term glomerular dysfunction after childhood cancer nephrectomy: what is the impact of nephrectomy and obesity?	32
Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy	31
Inadvertent stem cell transfer demonstrating a way for tolerance induction	31
Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease	31
Journal Club	31
Kidney epithelial targeted mitochondrial transcription factor A deficiency results in progressive mitochondrial depletion associated with severe cystic disease	30
Multidisciplinary approaches for elucidating genetics and molecular pathogenesis of urinary tract malformations	30
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease	30
The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action	30
Renin-angiotensin aldosterone inhibitor use at hospital discharge among patients with moderate to severe acute kidney injury and its association with recurrent acute kidney injury and mortality	30

A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney disease	30
Deregulating iron-erythropoiesis regulation: transferrin receptor 2 as potential target for treating anemia in CKD	30
Including APOL1 alleles and ancestry adjustments improve a genome-wide polygenic CKD score	30
Modelling AKI in vitro: taking organoids to the next level	29
Klotho-derived peptide 6 ameliorates diabetic kidney disease by targeting Wnt/β-catenin signaling	29
Immune checkpoint inhibitor–associated electrolyte disorders: query of the Food and Drug Administration Adverse Event Reporting System	29
Complement in membranous nephropathy: what we thought we knew and what we really know	29
Local complement factor H protects kidney endothelial cell structure and function	29
Effect of disease progression on the podocyte cell cycle in Alport Syndrome	29
Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case–noncase study	29
Diet–microbiota interaction and kidney disease progression	28
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation	28
Do we need to treat chronic active T cell–mediated rejection?	28
Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis	28
Posaconazole-induced podocyte phospholipidosis	28
Noninvasive screening of vancomycin-associated cast nephropathy	28
Editorial Board	27
Enhancing kidney organoid maturity with inducible vascularization: another step forward for in vitro modeling	27
Thirty years of the International Banff Classification for Allograft Pathology: the past, present, and future of kidney transplant diagnostics	27
Tubular glycogen nuclei in a patient with glycogen storage disease type Ia	27
Perirenal IgG4-related disease	27
Misuse of the Cox proportional hazards model and alternative approaches in kidney outcome research	27
Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain	27
The Case | Late allograft dysfunction with unexpected biopsy findings	27
A pig kidney supporting human physiology	26
Seeing through the density of dense deposit disease	26
Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease	26
Bacillus Calmette-Guérin–induced kidney granulomas	26
Targeting energy pathways in kidney disease: the roles of sirtuins, AMPK, and PGC1α	26
Kidney health for all: preparedness for the unexpected in supporting the vulnerable	25
SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population	25
Hereditary hypophosphatemic rickets with hypercalciuria (HHRH), a complex disorder in need of precision medicine	25
Targeted-release budesonide in recurrent IgA nephropathy after kidney transplantation	25
Glomerular-tubular crosstalk via cold shock Y-box binding protein-1 in the kidney	25
Cardiac screening prior to renal transplantation—good intentions, rather than good evidence, dictate practice	24
A case of membranous nephropathy following Pfizer–BioNTech mRNA vaccination against COVID-19	24
A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis	24
Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy	24
Performance of the Cockcroft-Gault, Modification of Diet in Renal Disease, and new Chronic Kidney Disease Epidemiology Collaboration equations without race in older acute medical patients	24
Relapse of class V lupus nephritis after vaccination with COVID-19 mRNA vaccine	24
Phosphate meeting cholesterol—consequences for cardiovascular disease in chronic kidney disease?	24
Urine trumps the protocol biopsy for subclinical rejection surveillance	24
Models of care to address disparities in kidney health outcomes for First Nations people	24
My, oh, MYO9A! Just how complex can regulation of the podocyte actin cytoskeleton get?	24
Pax protein depletion in proximal tubules triggers conserved mechanisms of resistance to acute ischemic kidney injury preventing transition to chronic kidney disease	24
An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis	24
Editorial Board	23
Tissue-resident macrophages mediate neutrophil recruitment and kidney injury in shiga toxin-induced hemolytic uremic syndrome	23
A new alternative: inhibiting complement activation in patients with IgA nephropathy	23
Renin and renin blockade have no role in complement activity	23
A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes	23
A stepped wedge cluster randomized trial of graphical surveillance of kidney function data to reduce late presentation for kidney replacement therapy	23
SGLT-2 inhibition in IgA nephropathy: the new standard of care?	23
The randomized controlled trial (NAVKIDS2) of a patient navigator program created for children with chronic kidney disease	23
A novel claudin-10 mutation with a unique mechanism in two unrelated families with HELIX syndrome	23
Bone histomorphometry for the diagnosis of renal osteodystrophy: a call for harmonization of reference ranges	23
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome	23
A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis	22
Deciphering the kidney hemodynamic effects of SGLT2 inhibition: translating insights from rats to humans in type 2 diabetes	22
The authors reply	22
Anakinra-associated renal amyloidosis	22
Long-term immunological outcomes of early subclinical inflammation on surveillance kidney allograft biopsies	22
The Case | Obstructive acute renal failure due to acute uric acid nephrolithiasis	22
Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis	22
How the amyloid fibril has unraveled: lessons for nephrology	22
Back to the future: the uncharted role of T cells in chronic and unexplained microvascular inflammation	22
Unfair enough: the cosmetic-TIM-kidney syndromes	22
Reconstructing the interface between the human intestine and immune system: potential to advance mechanistic studies in IgA nephropathy	21
Targeting APRIL in the treatment of glomerular diseases	21
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today	21
Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts	21
Improving frozen section evaluation of procurement donor kidney biopsies and reducing the discard rate: a promising role for artificial intelligence	21
New advances in endocrine hypertension: from genes to biomarkers	21
A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope	21
High rates of long-term renal recovery in survivors of coronavirus disease 2019–associated acute kidney injury requiring kidney replacement therapy	21
Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements	21
The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration	21
Unusual cause of retroperitoneal leak in a patient undergoing peritoneal dialysis	21
Dietary potassium loads call on intercalated cell PIEZO1 to go with the flow	21
Arterial stiffness, endothelial dysfunction and impaired fibrinolysis are pathogenic mechanisms contributing to cardiovascular risk in ANCA-associated vasculitis	21
Environmental pollution to kidney disease: an updated review of current knowledge and future directions	20
Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients	20
Molecular programs associated with glomerular hyperfiltration in early diabetic kidney disease	20
Editorial Board	20
Unlocking the potential of extracellular vesicles in nephrology: what does MISEV2023 add?	20
A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?	20
A tool for decision-making in kidney transplant candidates with poor prognosis to receive deceased donor transplantation in the United States	20
Fluid volume management in hemodialysis: never give up!	20
A choice experiment of older patients’ preferences for kidney failure treatments	20
Shared decision-making in hemodialysis vascular access practice	20
Identification of the gut microbial enzyme turning the urine yellow	20
Biallelic pathogenic variants in roundabout guidance receptor 1 associate with syndromic congenital anomalies of the kidney and urinary tract	20
The state of the global nephrology workforce: a joint ASN–ERA-EDTA–ISN investigation	20
Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement	20
Unpicking the multiomic response to endurance training: relevance for exercise benefits in chronic kidney disease	20